About T-ceptor Bio

At T-ceptor Bio we are reimagining the approach to treating autoimmune diseases by creating a modular biologic drug platform that will treat autoimmunity at its source. 

Develop life changing treatments for underserved patient populations. 

 Founder and CEO 

 Immunologist and biotech founder with deep expertise in T-cell biology and autoimmune disease; leads T-ceptor Bio’s strategy and scientific vision to develop first-in class, tissue- targeted immune therapies. 

Co-Founder and CTO 

 Protein engineer and structural biologist with expertise in antibody design and therapeutic platform development; drives T-ceptor Bio’s Fab-CKA discovery and translational execution. 

Finance and Business System Manager 

SAB Member

 Globally recognized expert in T cell regulation and autoimmunity; pioneering research defining how T cells control inflammation and immune balance.  

SAB Member

 Biologics discovery leader with 30+ years of experience at Novartis, Pfizer, and Biogen Idec; co-inventor on 20+ patents and contributor to 50+ therapeutic programs. 

 Advisor 

 Co-founder and strategist behind Enzymatics (acquired by Qiagen) and Watchmaker Genomics; former corporate development lead at ArcherDX. 

 Advisor 

 CEO of AxisVet and seasoned life-science executive with over 25 years of experience leading biotech and healthcare companies through growth, capital raises exceeding $100M, and more than 20 successful M&A transactions.